What is BPC-157? Research Overview & Mechanism of Action

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide — a chain of 15 amino acids — derived from a body protection compound naturally found in human gastric juice. With the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val and CAS number 137525-51-0, it is one of the most widely published peptides in preclinical literature.

What Makes BPC-157 Unique?

Unlike many research peptides, BPC-157 demonstrates exceptional stability in human gastric juice — the environment from which it was originally isolated. This stability is thought to underpin its broad preclinical activity profile, and distinguishes it from peptides that degrade rapidly in biological fluids.

BPC-157 has been studied in over 100 preclinical publications spanning angiogenesis, gastroenterology, neuroscience, and musculoskeletal research, making it one of the most researched compounds in its class.

Mechanisms Studied in Preclinical Research

Research into BPC-157 has identified several key mechanistic pathways of interest:

  • Angiogenesis and VEGF signalling: BPC-157 has been shown to upregulate vascular endothelial growth factor (VEGF) and new vessel formation in vascular models.
  • Nitric oxide (NO) pathway modulation: Research demonstrates BPC-157's ability to modulate endothelial nitric oxide synthase (eNOS) activity, central to vascular biology.
  • EGF receptor interaction: Studies suggest BPC-157 interacts with EGF receptor signalling pathways involved in cell proliferation and migration.
  • Neurotransmitter modulation: Preclinical models have investigated BPC-157's influence on dopaminergic and serotonergic signalling pathways.
  • Gastrointestinal mucosal protection: Among its most documented research applications, BPC-157 has been studied extensively in GI mucosal models.

Research Applications

In the laboratory setting, BPC-157 is used in research across several areas: tendon, ligament, muscle, and bone cell models; angiogenesis and cell-migration research; GI mucosal biology including ulcer and IBD models; neurological pathway investigation; and nitric oxide signalling in vascular biology.

Purity and Formulation

At Peptide Biosciences, BPC-157 is supplied as lyophilised (freeze-dried) powder with a purity of 99%+ verified by HPLC analysis. Each batch is independently tested with certificates of analysis available on our COA page. Available in 5mg and 10mg vials.

Regulatory Status

BPC-157 is not a licensed medicine in the UK and must not be presented or used as one. Peptide Biosciences supplies it only for in vitro laboratory research, and refuses orders where the intended use appears to be human or veterinary administration. Researchers should confirm the regulatory requirements that apply to their own work and take independent advice where needed.

All products supplied by Peptide Biosciences are for in vitro laboratory research use only by qualified scientific professionals. Not for human consumption.

Back to blog